Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
NAUT on Nasdaq
Shares outstanding
126,882,307
Price per share
$1.95
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
57,899,311
Total reported value
$48,912,774
% of total 13F portfolios
0%
Share change
-1,864,178
Value change
-$1,403,087
Number of holders
65
Price from insider filings
$1.95
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Mallick Parag 17% $15,807,377 22,263,911 Parag Mallick 03 Mar 2025
Patel Sujal M 16% $14,411,390 20,297,732 Sujal Patel 03 Mar 2025
PERCEPTIVE ADVISORS LLC 10% +1% $11,149,148 +$192,185 12,815,113 +1.8% Perceptive Advisors LLC 20 Jun 2025

As of 30 Sep 2025, 65 institutional investors reported holding 57,899,311 shares of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT). This represents 46% of the company’s total 126,882,307 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) together control 45% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
a16z Capital Management, L.L.C. 14% 17,653,917 0% 1.1% $14,915,794
PERCEPTIVE ADVISORS LLC 9.9% 12,594,211 0% 0.31% $10,642,108
Cercano Management LLC 5.7% 7,172,985 0% 0.23% $6,060,455
Madrona Venture Group, LLC 4.7% 6,020,770 0% 37% $5,087,000
VANGUARD GROUP INC 1.9% 2,431,829 -2.1% 0% $2,054,896
Comprehensive Financial Management LLC 1.7% 2,207,619 0% 0.05% $1,865,217
AMAZON COM INC 1.1% 1,457,055 0% 0.05% $1,231,211
Clarius Group, LLC 0.95% 1,209,646 +14% 0.06% $1,021,862
RENAISSANCE TECHNOLOGIES LLC 0.79% 1,007,662 +63% 0% $851,374
MILLENNIUM MANAGEMENT LLC 0.76% 967,548 -8.4% 0% $817,481
Tikvah Management LLC 0.57% 726,895 0% 0.19% $614,154
GEODE CAPITAL MANAGEMENT, LLC 0.44% 553,602 0% 0% $467,858
DIMENSIONAL FUND ADVISORS LP 0.29% 364,675 -34% 0% $307,807
Corient Private Wealth LLC 0.25% 319,140 -27% 0% $269,641
JACOBS LEVY EQUITY MANAGEMENT, INC 0.24% 301,012 +18% 0% $254,325
GSA CAPITAL PARTNERS LLP 0.2% 259,203 +47% 0.02% $219,000
CITADEL ADVISORS LLC 0.2% 254,161 +43% 0% $214,741
Alyeska Investment Group, L.P. 0.2% 253,468 0% 0% $214,155
ACADIAN ASSET MANAGEMENT LLC 0.19% 243,273 +252% 0% $203,000
BlackRock, Inc. 0.16% 201,444 -68% 0% $170,200
HILLMAN CO 0.16% 200,000 0% 0.05% $168,980
STATE STREET CORP 0.14% 178,755 -1.6% 0% $151,030
JANE STREET GROUP, LLC 0.12% 148,188 -49% 0% $125,204
Crewe Advisors LLC 0.11% 136,052 0.01% $114,951
Squarepoint Ops LLC 0.1% 131,827 +29% 0% $111,381

Institutional Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,607,362 $3,134,057 -$1,286 $1.95 6
2025 Q3 57,899,311 $48,912,774 -$1,403,087 $0.84 65
2025 Q2 59,755,012 $43,314,600 -$2,449,905 $0.72 67
2025 Q1 62,775,437 $54,045,644 -$1,026,756 $0.86 86
2024 Q4 63,869,661 $107,299,374 -$821,201 $1.68 86
2024 Q3 64,190,100 $182,943,834 +$1,290,455 $2.85 81
2024 Q2 63,999,578 $149,759,950 +$1,608,547 $2.34 75
2024 Q1 63,240,413 $185,925,873 -$499,885 $2.94 70
2023 Q4 63,424,716 $189,647,655 +$5,847,645 $2.99 74
2023 Q3 45,082,721 $142,463,072 +$769,963 $3.16 74
2023 Q2 44,814,450 $173,427,573 +$1,498,150 $3.87 74
2023 Q1 44,499,314 $123,255,982 -$1,802,223 $2.77 72
2022 Q4 46,081,461 $82,942,228 -$2,657,044 $1.80 78
2022 Q3 56,460,432 $119,696,429 -$2,490,160 $2.12 77
2022 Q2 57,502,356 $154,669,821 +$297,442 $2.69 80
2022 Q1 56,024,124 $243,509,430 -$20,551,922 $4.34 79
2021 Q4 41,913,282 $217,115,889 +$1,259,255 $5.18 77
2021 Q3 40,974,903 $245,092,558 +$9,814,243 $6.14 68
2021 Q2 33,010,619 $331,901,744 +$331,901,478 $10.10 55